Skip to main content

Galvanize Therapeutics

San Carlos, United States

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

$100.0M raised
Sep 2025
Series C

Top Investors

NorwestSofinnova PartnersJanus Henderson InvestorsAlly Bridge GroupFidelity

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Galvanize Therapeutics

How much funding has Galvanize Therapeutics raised?
Galvanize Therapeutics has raised $100.0M in total funding. The most recent round was Series C. The last funding was announced in September 2025.
Who are Galvanize Therapeutics's investors?
Galvanize Therapeutics's investors include Norwest, Sofinnova Partners, Janus Henderson Investors, Ally Bridge Group, Fidelity.
Where is Galvanize Therapeutics headquartered?
Galvanize Therapeutics is headquartered in San Carlos, United States.
What does Galvanize Therapeutics do?
Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.
What stage is Galvanize Therapeutics at?
Galvanize Therapeutics is at the Series C stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Galvanize Therapeutics — Funding & Investors." VCBacked, September 3, 2025, https://www.vcbacked.co/company/galvanize-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2025). Galvanize Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/galvanize-therapeutics
Wikipedia (cite web)
{{cite web |title=Galvanize Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/galvanize-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .